1.How thoroughly have you inventoried all supplemental health products offered (accident, critical illness, cancer, hospital indemnity) and mapped their covered events?
A complete product inventory is the starting point for overlap analysis. Many employers offer products without a clear picture of total coverage.
2.How carefully have you analyzed the overlap between your cancer insurance and critical illness insurance covered conditions?
Cancer is typically covered by both CI and cancer insurance. Offering both without analysis often results in over-insurance for cancer and under-insurance for other conditions.
3.How carefully have you analyzed the overlap between your accident insurance and hospital indemnity for accident-related hospitalizations?
Both accident and hospital indemnity pay for accident-related hospitalizations. The combined benefit may exceed actual out-of-pocket costs.
4.How well do you evaluate the total employee cost of the supplemental health portfolio relative to the protection value delivered?
Employees paying for multiple overlapping products may be over-insured in some areas and under-insured in others.
5.How actively do you rationalize your supplemental health portfolio to eliminate redundancy and fill genuine gaps?
Annual portfolio review with a documented rationalization framework is the benchmark. Fewer, better-designed products typically outperform a large overlapping portfolio.
This tool provides educational decision support only. Results are not legal, tax, actuarial, or insurance advice. Validate all outputs against current plan documents, applicable law, and qualified professional guidance. Scoring version 1.0 · Reference year 2026.
